- Home
- BMRA vs AEON Comparison
BMRA vs AEON Comparison
Compare BMRA & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- AEON
- Stock Information
- Founded
- BMRA 1971
- AEON N/A
- Country
- BMRA United States
- AEON United States
- Employees
- BMRA N/A
- AEON N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- BMRA Health Care
- AEON Health Care
- Exchange
- BMRA Nasdaq
- AEON Nasdaq
- Market Cap
- BMRA 8.2M
- AEON 8.0M
- IPO Year
- BMRA N/A
- AEON N/A
- Fundamental
- Price
- BMRA N/A
- AEON $0.92
- Analyst Decision
- BMRA
- AEON Strong Buy
- Analyst Count
- BMRA 0
- AEON 1
- Target Price
- BMRA N/A
- AEON $7.20
- AVG Volume (30 Days)
- BMRA 33.1K
- AEON 139.8K
- Earning Date
- BMRA 10-10-2025
- AEON 11-12-2025
- Dividend Yield
- BMRA N/A
- AEON N/A
- EPS Growth
- BMRA N/A
- AEON N/A
- EPS
- BMRA N/A
- AEON N/A
- Revenue
- BMRA $5,311,000.00
- AEON N/A
- Revenue This Year
- BMRA N/A
- AEON N/A
- Revenue Next Year
- BMRA N/A
- AEON N/A
- P/E Ratio
- BMRA N/A
- AEON N/A
- Revenue Growth
- BMRA N/A
- AEON N/A
- 52 Week Low
- BMRA $2.08
- AEON $0.38
- 52 Week High
- BMRA $10.16
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- BMRA 45.61
- AEON 73.70
- Support Level
- BMRA $2.68
- AEON $0.78
- Resistance Level
- BMRA $2.83
- AEON $0.85
- Average True Range (ATR)
- BMRA 0.11
- AEON 0.04
- MACD
- BMRA 0.01
- AEON 0.02
- Stochastic Oscillator
- BMRA 54.84
- AEON 100.00
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.